You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania
|
|---|---|
| Published in |
Malaria Journal, May 2014
|
| DOI | 10.1186/1475-2875-13-181 |
| Pubmed ID | |
| Authors |
Inez Mikkelsen-Lopez, Winna Shango, Jim Barrington, Rene Ziegler, Tom Smith, Don deSavigny |
| Abstract |
Between 2007 and 2013, the Tanzanian public sector received 93.1 million doses of first-line anti-malarial artemisinin-based combination therapy (ACT) in the form of artemether-lumefantrine entirely supplied by funding partners. The introduction of a health facility ACT stock monitoring system using SMS technology by the National Malaria Control Programme in mid 2011 revealed a high frequency of stock-outs of ACT in primary care public health facilities. The objective of this study was to determine the pattern of availability of ACT and possible causes of observed stock-outs across public health facilities in Tanzania since mid-2011. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
| Members of the public | 1 | 33% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| Tanzania, United Republic of | 1 | <1% |
| Switzerland | 1 | <1% |
| Netherlands | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 180 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 39 | 21% |
| Researcher | 32 | 17% |
| Student > Ph. D. Student | 20 | 11% |
| Lecturer | 11 | 6% |
| Student > Bachelor | 10 | 5% |
| Other | 34 | 18% |
| Unknown | 41 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 13% |
| Social Sciences | 25 | 13% |
| Nursing and Health Professions | 24 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 7% |
| Computer Science | 11 | 6% |
| Other | 38 | 20% |
| Unknown | 51 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2015.
All research outputs
#14,780,519
of 22,755,127 outputs
Outputs from Malaria Journal
#4,228
of 5,552 outputs
Outputs of similar age
#127,784
of 227,133 outputs
Outputs of similar age from Malaria Journal
#61
of 103 outputs
Altmetric has tracked 22,755,127 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,552 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,133 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.